HUM Humana Inc. Common Stock
NYSE · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 七月 29, 2026HUM 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
HUM 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 1991年8月1日 | 3-for-2 | 正向 |
| 1984年2月1日 | 6-for-5 | 正向 |
| 1983年2月1日 | 4-for-3 | 正向 |
| 1982年2月1日 | 3-for-2 | 正向 |
关于 Humana Inc. Common Stock 公司概况(来自维基百科)
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list. It is the fourth largest health insurance provider in the U.S.
History
1961–1983: Nursing homes and hospitals
Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).
In 1974, the partners changed the corporate name to Humana Inc. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s.
1984–present
As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."
In 1993, Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.
In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value.
In 2010, Humana returned to providing healthcare services when it bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million. They went on to sell Concentra again in 2015 for $1 billion.
In July 2015, Aetna announced that it would acquire Humana for $37 billion. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna and Humana cancelled a $34 billion merger agreement after judges ruled against the merger for a second time.
In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million.
In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO.
In 2024 Humana announced that they would be leaving the Humana Building, which they had occupied since the 1980s, in order to cut costs. Humana said that it planned to consolidate its workforce in its Waterside-Clocktower campus.
In 2026 KFF reported that Humana was the second-largest parent organization for Medicare Advantage by overall enrollment, and that it had the largest growth in that sector that year.
Humana Military Healthcare Services
In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.
In 2009, HMHS' contract with the military was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.
Legal campaign against drug price fixing
Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.
Controversy
In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.
On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.
In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.
Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.
On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.
来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
| 指标 | 5年趋势 | HUM | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 36.75年均值 ≈23.6 | ≈23.6 | 36.3 | 估值过高 | |
| P/S (TTM) | 0.55年均值 ≈0.7 | ≈0.7 | 0.7 | 低估 | |
| 市净率 (MRQ) | 4.05年均值 ≈4.6 | ≈4.6 | 3.9 | 公允价值 | |
| EV / EBITDA (企业价值 / EBITDA) | 25.85年均值 ≈19.0 | ≈19.0 | 16.1 | 公允价值 | |
| 股价/自由现金流 (TTM) | 39.65年均值 ≈54.2 | ≈54.2 | · | · | |
| 市现率 (TTM) | 30.45年均值 ≈29.3 | ≈29.3 | 15.6 | 估值过高 | |
| 市值/营收 (TTM) | 0.45年均值 ≈0.6 | ≈0.6 | · | · | |
| 市值/自由现金流 (TTM) | 33.55年均值 ≈46.5 | ≈46.5 | · | · | |
| 市净率(有形资产) (MRQ) | 4.35年均值 ≈14.5 | ≈14.5 | · | · |
同行中位数按每项指标的标准化基础计算,可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | HUM | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | 1.9%5年均值 ≈3.2% | ≈3.2% | 3.5% | 弱 | |
| EBITDA Margin (息税折旧摊销前利润率) | 2.1%5年均值 ≈3.2% | ≈3.2% | 3.7% | 弱 | |
| 税前利润率 (TTM) | 1.1%5年均值 ≈2.7% | ≈2.7% | 2.8% | 弱 | |
| 净利润率 (TTM) | 0.88%5年均值 ≈2.2% | ≈2.2% | 2.9% | 弱 | |
| ROA (TTM) | 2.4%5年均值 ≈4.9% | ≈4.9% | 3.0% | 弱 | |
| ROE (TTM) | 6.8%5年均值 ≈13.3% | ≈13.3% | 10.1% | 弱 | |
| ROIC | 7.4%5年均值 ≈9.7% | ≈9.7% | 8.0% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | HUM | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 0.65年均值 ≈0.7 | ≈0.7 | 0.7 | 低负债 | |
| 流动比率 (MRQ) | 1.75年均值 ≈1.7 | ≈1.7 | 1.7 | 流动性强 | |
| 速动比率 (MRQ) | 1.35年均值 ≈1.3 | ≈1.3 | 1.3 | 持平 | |
| 长期负债/股东权益 (MRQ) | 0.65年均值 ≈0.7 | ≈0.7 | 0.7 | 低负债 |
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | HUM | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 10.1%5年均值 ≈11.0% | ≈11.0% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 11.8%5年均值 ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 10.9% | · | · | · | |
| EPS YoY | -1.4%5年均值 ≈-14.8% | ≈-14.8% | · | · | |
| Net Income YoY (净利润同比增长) | -1.6%5年均值 ≈-16.3% | ≈-16.3% | · | · | |
| EPS CAGR 3Y (每股收益年复合增长率(3年)) | -23.6%5年均值 ≈-18.4% | ≈-18.4% | · | · | |
| EPS CAGR 5Y (每股收益年复合增长率(5年)) | -17.2% | · | · | · | |
| Net Income CAGR 3Y (净利润年复合增长率(3年)) | -24.9%5年均值 ≈-20.0% | ≈-20.0% | · | · | |
| Net Income CAGR 5Y (净利润年复合增长率(5年)) | -18.8% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | HUM | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 2.75年均值 ≈2.4 | ≈2.4 | 2.4 | 持平 | |
| Receivables Turnover (应收账款周转率) | 43.45年均值 ≈52.0 | ≈52.0 | 16.3 | 顶尖 | |
| Revenue / Employee (年营业收入 ÷ 员工人数(报告的 headcount,yfinance)。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$1.9M | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
股息 收益率、派息率、股息历史、5年CAGR
| 除息日 | 金额 | 货币 | 收益率 |
|---|---|---|---|
| 六月 26, 2026 | $0.89 | USD | ≈0.92% |
| 三月 27, 2026 | $0.89 | USD | ≈2.1% |
| 十二月 26, 2025 | $0.89 | USD | ≈1.4% |
| 九月 26, 2025 | $0.89 | USD | ≈1.4% |
| 六月 27, 2025 | $0.89 | USD | ≈1.5% |
| 三月 28, 2025 | $0.89 | USD | ≈1.3% |
| 十二月 31, 2024 | $0.89 | USD | ≈1.4% |
| 九月 30, 2024 | $0.89 | USD | ≈1.1% |
| 六月 28, 2024 | $0.89 | USD | ≈0.95% |
| 三月 27, 2024 | $0.89 | USD | ≈1.0% |
| 十二月 28, 2023 | $0.89 | USD | ≈0.78% |
| 九月 28, 2023 | $0.89 | USD | ≈0.70% |
| 六月 29, 2023 | $0.89 | USD | ≈0.75% |
| 三月 30, 2023 | $0.89 | USD | ≈0.67% |
| 十二月 29, 2022 | $0.79 | USD | ≈0.61% |
| 九月 29, 2022 | $0.79 | USD | ≈0.62% |
| 六月 29, 2022 | $0.79 | USD | ≈0.64% |
| 三月 30, 2022 | $0.79 | USD | ≈0.66% |
| 十二月 30, 2021 | $0.70 | USD | ≈0.60% |
| 九月 29, 2021 | $0.70 | USD | ≈0.69% |
收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 七月 29, 2026 | $7.61 | $7.29 | 4.3% |
| 2026年3月31日 | $10.31 | $10.29 | 0.21% | |
| 2025年12月31日 | $-3.96 | $-4.05 | 2.1% | |
| 2025年9月30日 | $3.24 | $2.85 | 13.8% | |
| 2025年6月30日 | $6.27 | $5.98 | 4.9% | |
| 2025年3月31日 | $11.58 | $10.17 | 13.9% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| SG&A Expense | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B | $6.57B | $7.17B | $7.29B | $7.64B | |
| Operating Income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B | |
| Interest Expense | · | · | $493M | $401M | $326M | $283M | $242M | $218M | $242M | $189M | $186M | $192M | |
| Other Non-op | $-451M | $-181M | $-137M | $-68M | $532M | $-103M | $506M | $-33M | $0 | $0 | · | · | |
| Pretax Income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B | $4.67B | $3.47B | $2.07B | $4.02B | $1.55B | $2.43B | $2.17B | |
| Income Tax | $250M | $413M | $836M | $762M | $485M | $1.31B | $763M | $391M | $1.57B | $938M | $1.16B | $1.02B | |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 | $16.94 | $4.11 | $8.54 | $7.44 | |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | |
| Shares (Basic) | 120,454,000 | 120,571,000 | 123,866,000 | 126,419,000 | 128,688,000 | 132,199,000 | 134,055,000 | 137,486,000 | 144,493,000 | 149,375,000 | 149,455,000 | 154,187,000 | |
| Shares (Diluted) | 120,826,000 | 120,869,000 | 124,441,000 | 127,094,000 | 129,396,000 | 133,012,000 | 134,727,000 | 138,403,000 | 145,585,000 | 150,917,000 | 151,142,000 | 155,874,000 | |
| EBITDA | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B | $2.57B | $1.94B | |
| Short-term Investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B | $12.55B | $10.97B | · | · | · | · | · | |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B | $1.14B | $1.06B | $1.01B | $854M | $1.28B | $1.16B | $1.05B | |
| Other Current Assets | $9.56B | $6.68B | $6.63B | $5.57B | $6.49B | $5.28B | $3.81B | $3.56B | $2.95B | $3.44B | $4.71B | $4.01B | |
| Current Assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B | $15.71B | $15.54B | |
| PP&E (Net) | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B | $2.37B | $1.96B | $1.74B | $1.58B | $1.50B | $1.38B | $1.23B | |
| PP&E (Gross) | $5.52B | $5.67B | $5.88B | $6.36B | $5.95B | $5.49B | $4.62B | $4.05B | $3.56B | $3.19B | $2.72B | $2.91B | |
| Accum. Depreciation | $3.29B | $3.14B | $2.85B | $3.14B | $2.87B | $3.12B | $2.66B | $2.31B | $1.98B | $1.69B | $1.34B | $1.68B | |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B | $4.45B | $3.93B | $3.90B | $3.28B | $3.27B | $3.27B | $3.23B | |
| Intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B | $329M | $177M | $245M | $226M | $280M | $357M | $440M | |
| Other Non-current Assets | $3.13B | $3.38B | $3.38B | $3.38B | $4.38B | $2.13B | $1.83B | $1.38B | $2.17B | $2.23B | $2.48B | $1.58B | |
| Total Assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Accounts Payable | $5.72B | $5.26B | $6.57B | $5.24B | $4.51B | $4.01B | $3.75B | $3.07B | $4.07B | $2.47B | $2.21B | $2.10B | |
| Short-term Debt | · | · | · | · | · | · | · | $1.69B | $150M | $300M | $299M | $0 | |
| Current Liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B | $13.39B | $10.93B | $10.08B | $9.41B | $7.82B | $8.15B | $7.47B | |
| Capital Leases | $418M | $392M | $444M | $456M | $546M | $355M | $332M | · | · | · | · | · | |
| Other Non-current Liabilities | $2.46B | $1.95B | $1.66B | $1.47B | $2.38B | $1.79B | $1.14B | $581M | $237M | $263M | $235M | $236M | |
| Total Liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B | $14.33B | $13.88B | |
| Total Debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $6.07B | $4.92B | $4.09B | $4.12B | $3.83B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | |
| Retained Earnings | $29.07B | $28.32B | $27.54B | $25.49B | $23.09B | $20.52B | $17.48B | $15.07B | $13.67B | $11.45B | $11.02B | $9.92B | |
| Treasury Stock | $14.42B | $14.37B | $13.66B | $12.16B | $10.16B | $9.92B | $8.46B | $7.32B | $6.33B | $3.30B | $3.29B | $2.86B | |
| AOCI | $-633M | $-1.07B | $-999M | $-1.30B | $42M | $391M | $156M | $-159M | $19M | $-66M | $58M | $223M | |
| Stockholders' Equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B | $10.35B | $9.65B | |
| Liabilities + Equity | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Shares Outstanding | 198,719,000 | 198,719,000 | 198,690,000 | 198,667,000 | 198,649,000 | 198,649,000 | 198,630,000 | · | · | · | · | · |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $698M | $839M | $779M | $709M | $596M | · | · | $444M | $410M | $388M | $354M | $328M | |
| Stock-based Comp | $241M | $207M | $175M | $216M | $180M | $181M | $163M | $137M | $157M | $115M | $109M | $98M | |
| Deferred Tax | $75M | $-192M | $-164M | $-100M | $15M | $195M | $162M | $194M | $132M | $-71M | $-2M | $-64M | |
| Amort. of Intangibles | $51M | $60M | $67M | $81M | $65M | $88M | $70M | $90M | $75M | $77M | $93M | $121M | |
| Restructuring | · | · | · | · | · | · | $47M | · | $148M | · | · | · | |
| Operating Cash Flow | $921M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B | $868M | $1.62B | |
| CapEx | $546M | $575M | $1.00B | $1.14B | $1.34B | $964M | $736M | $612M | $524M | $527M | $523M | $528M | |
| Investing Cash Flow | $2.27B | $-2.95B | $-3.49B | $-1.01B | $-6.56B | $-3.06B | $-1.28B | $-3.09B | $-2.94B | $-1.36B | $320M | $-63M | |
| Net Debt Issued | · | · | · | · | · | · | $-400M | $0 | $-800M | $0 | $0 | $-500M | |
| Stock Repurchased | $151M | $817M | $1.57B | $2.10B | $79M | $1.82B | $1.07B | $1.09B | $3.37B | $104M | $385M | $872M | |
| Net Stock Activity | $-151M | $-817M | $-1.57B | $-2.10B | $-79M | $-1.82B | $-1.07B | $-1.09B | $-3.37B | $-104M | $-385M | $-872M | |
| Dividends Paid | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M | |
| Financing Cash Flow | $-1.22B | $-2.49B | $-856M | $-1.91B | $3.02B | $-1.96B | $-2.29B | $-785M | $-945M | $732M | $-552M | $-758M | |
| Net Change in Cash | $1.98B | $-2.47B | $-367M | $1.67B | $-1.28B | $619M | $1.71B | $-1.70B | $165M | $1.31B | $636M | $797M | |
| Taxes Paid | · | $570M | $997M | $758M | $227M | $1.13B | $518M | $631M | $1.50B | $916M | $1.18B | $1.03B | |
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M | $4.67B | $4.55B | $1.56B | $3.52B | $1.41B | $345M | $1.09B | |
| Levered FCF | · | · | $2.61B | $3.15B | $666M | $4.47B | $4.36B | $1.38B | $3.38B | $1.33B | $247M | $989M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| Net Margin | 0.92% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% | 2.4% | 2.4% | |
| Pretax Margin | 1.1% | 1.5% | 3.1% | 3.8% | 4.1% | 6.1% | 5.3% | 3.6% | 7.5% | 2.9% | 4.5% | 4.5% | |
| EBITDA Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| ROA | 2.5% | 2.6% | 5.5% | 6.4% | 7.4% | 10.5% | 9.9% | 6.4% | 9.3% | 2.5% | 5.3% | 5.2% | |
| ROE | 7.0% | 7.4% | 15.8% | 18.2% | 18.1% | 22.8% | 22.9% | 16.2% | 23.3% | 5.8% | 12.8% | 12.1% | |
| ROIC | 7.4% | 7.1% | 11.3% | 12.3% | 10.1% | 18.1% | 14.6% | 15.5% | 17.6% | 4.7% | 8.5% | 9.3% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 | 1.8 | 1.8 | 1.7 | 1.9 | 2.1 | 1.9 | 2.0 | |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.4 | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | |
| Interest Coverage | · | · | 8.1 | 9.5 | 9.7 | 17.6 | 13.2 | 14.2 | 17.6 | 9.2 | 12.6 | 12.3 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.7 | 2.5 | 2.4 | 2.1 | 2.1 | 2.4 | 2.4 | 2.2 | 2.0 | 2.2 | 2.3 | 2.2 | |
| Receivables Turnover | 43.4 | 49.7 | 57.4 | 53.3 | 56.3 | 70.3 | 62.7 | 60.9 | 50.4 | 44.6 | 49.0 | 45.8 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $88.85 | $82.40 | $81.85 | $77.07 | · | · | · | · | · | · | · | · | |
| Revenue / Share | $1073.15 | $974.29 | $854.81 | $730.72 | $641.94 | $580.06 | $481.63 | $411.20 | $369.32 | $360.32 | $359.19 | $311.15 | |
| Cash Flow / Share | $7.62 | $24.54 | $31.99 | $36.09 | $17.48 | $42.39 | $39.22 | $15.70 | $27.83 | $12.83 | $5.74 | $10.38 | |
| Cash / Share | $21.14 | $11.18 | $23.62 | $25.47 | · | · | · | · | · | · | · | · | |
| Dividend / Share | · | · | · | · | · | · | · | · | · | $1.16 | $1.15 | $1.11 | |
| Dividend Paid / Share | $3.54 | $3.54 | $3.44 | $3.06 | $2.73 | $2.43 | $2.15 | $1.90 | $1.49 | $1.16 | $1.14 | $1.10 | |
| EPS (TTM) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 10.7% | 14.5% | 11.8% | 7.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.8% | 12.3% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.4% | -50.1% | -9.4% | -2.6% | -10.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -23.6% | -23.9% | -7.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | -51.5% | -11.3% | -4.3% | -12.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -25.6% | -9.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -18.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| Net Income TTM | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| Market Cap | $50.90B | $50.42B | $90.96B | $101.76B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $43.36B | $41.13B | $79.86B | $91.85B | · | · | · | · | · | · | · | · | |
| P/E | 26.0 | 25.4 | 22.9 | 23.2 | 20.5 | 16.2 | 18.2 | 23.6 | 14.8 | 50.1 | 21.2 | 19.5 | |
| P/S | 0.4 | 0.4 | 0.9 | 1.1 | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 3.1 | 5.6 | 6.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 7.4 | 9.5 | 18.1 | 23.1 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.3 | 17.0 | 22.8 | 22.2 | · | · | · | · | · | · | · | · | |
| P / FCF | 135.7 | 21.1 | 30.6 | 29.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 16.0 | 16.1 | 19.9 | 24.2 | · | · | · | · | · | · | · | · | |
| EV / FCF | 115.6 | 17.2 | 26.8 | 26.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.3 | 0.3 | 0.8 | 1.0 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.84% | 0.85% | 0.47% | 0.39% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.8% | 3.9% | 4.4% | 4.3% | 4.9% | 6.2% | 5.5% | 4.2% | 6.8% | 2.0% | 4.7% | 5.1% | |
| Payout Ratio | 36.2% | 35.7% | 17.3% | 14.0% | 12.1% | 9.6% | 10.8% | 15.8% | 9.0% | 28.8% | 13.5% | 15.0% | |
| Annual Payout | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B | $29.40B | $29.54B | $29.61B | $26.46B | $26.42B | $26.75B | $26.74B | $22.44B | $22.80B | |
| SG&A Expense | $3.98B | $4.02B | $4.44B | $4.08B | $3.55B | $3.38B | $4.17B | $3.34B | $3.15B | $3.04B | $3.83B | $3.27B | $3.11B | $2.98B | $3.55B | $3.06B | |
| Operating Income | $1.36B | $1.75B | $-808M | $400M | $1.10B | $2.01B | $-543M | $728M | $1.14B | $1.24B | $-348M | $1.21B | $1.44B | $1.72B | $124M | $1.17B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $159M | · | $114M | $120M | $113M | · | $102M | |
| Other Non-op | $-211M | $34M | $-53M | $-35M | $-200M | $-163M | $-155M | $92M | $-55M | $-63M | $-97M | $6M | $-54M | $8M | $-84M | $-13M | |
| Pretax Income | $952M | $1.59B | $-1.13B | $134M | $741M | $1.69B | $-963M | $651M | $918M | $1.01B | $-610M | $1.09B | $1.25B | $1.60B | $-72M | $1.30B | |
| Income Tax | $238M | $395M | $-249M | $-86M | $179M | $406M | $-216M | $155M | $223M | $251M | $-75M | $256M | $296M | $359M | $-58M | $107M | |
| Net Income | $694M | $1.19B | $-796M | $195M | $545M | $1.24B | $-693M | $480M | $679M | $741M | $-541M | $832M | $959M | $1.24B | $-15M | $1.20B | |
| EPS (Basic) | $5.78 | $9.85 | $-6.58 | $1.62 | $4.52 | $10.31 | $-5.74 | $3.99 | $5.63 | $6.13 | $-4.26 | $6.74 | $7.70 | $9.91 | $-0.07 | $9.45 | |
| EPS (Diluted) | $5.73 | $9.83 | $-6.59 | $1.62 | $4.51 | $10.30 | $-5.73 | $3.98 | $5.62 | $6.11 | $-4.24 | $6.71 | $7.66 | $9.87 | $-0.08 | $9.39 | |
| Shares (Basic) | 120,066,000 | 120,332,000 | · | 120,273,000 | 120,539,000 | 120,666,000 | · | 120,405,000 | 120,445,000 | 120,978,000 | · | 123,426,000 | 124,574,000 | 125,005,000 | · | 126,572,000 | |
| Shares (Diluted) | 121,135,000 | 120,652,000 | · | 120,745,000 | 120,745,000 | 120,844,000 | · | 120,764,000 | 120,665,000 | 121,268,000 | · | 123,983,000 | 125,109,000 | 125,564,000 | · | 127,356,000 | |
| EBITDA | $1.36B | $1.75B | · | $400M | $1.10B | $2.01B | · | $728M | $1.14B | $1.24B | · | $1.21B | $1.44B | $1.72B | · | $1.17B |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B | $5.12B | $5.50B | $5.91B | · | $15.15B | $16.21B | $13.73B | · | $13.56B | |
| Short-term Investments | $16.98B | $17.01B | $15.70B | $16.74B | $17.67B | $17.89B | $18.21B | $19.03B | $17.42B | $16.70B | · | $15.14B | $15.25B | $14.93B | · | $13.12B | |
| Receivables | $5.70B | $5.22B | $3.27B | $2.68B | $4.50B | $4.46B | $2.70B | $2.14B | $4.09B | $3.92B | · | $1.82B | $1.43B | $3.11B | · | $1.61B | |
| Other Current Assets | $10.52B | $10.90B | $9.56B | $7.94B | $7.40B | $7.83B | $6.68B | $6.63B | $5.84B | $6.26B | · | $6.14B | $5.87B | $5.76B | · | $5.42B | |
| Current Assets | $40.09B | $38.08B | $32.73B | $32.75B | $33.62B | $34.42B | $29.82B | $32.93B | $32.86B | $32.80B | · | $38.25B | $38.76B | $37.53B | · | $33.71B | |
| PP&E (Net) | $2.10B | $2.17B | $2.23B | $2.27B | $2.36B | $2.43B | $2.53B | $2.69B | $2.82B | $2.98B | · | $3.34B | $3.31B | $3.23B | · | $3.22B | |
| PP&E (Gross) | · | · | $5.52B | · | · | · | $5.67B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.29B | · | · | · | $3.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $10.48B | $10.49B | $9.69B | $9.62B | $9.63B | $9.63B | $9.63B | $9.59B | $9.57B | $9.56B | $9.55B | $9.54B | $9.54B | $9.32B | $9.14B | $9.10B | |
| Intangibles | $1.18B | $1.19B | $1.13B | $1.23B | $1.38B | $1.43B | $1.44B | $1.65B | $1.66B | $1.68B | · | $1.76B | $1.78B | $1.75B | · | $1.80B | |
| Other Non-current Assets | $3.25B | $3.28B | $3.13B | $4.02B | $3.69B | $3.38B | $3.38B | $3.67B | $3.72B | $3.64B | · | $3.64B | $3.73B | $3.58B | · | $3.63B | |
| Total Assets | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Accounts Payable | $7.26B | $6.53B | $5.72B | $5.52B | $5.59B | $5.38B | $5.26B | $5.92B | $6.53B | $6.50B | · | $7.60B | $8.12B | $7.43B | · | $6.77B | |
| Current Liabilities | $23.01B | $21.51B | $16.35B | $16.18B | $17.22B | $18.04B | $16.94B | $18.73B | $19.79B | $19.69B | · | $27.82B | $28.28B | $26.94B | · | $25.05B | |
| Capital Leases | · | · | $418M | · | · | · | $392M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.93B | $2.85B | $2.46B | $2.35B | $2.26B | $2.34B | $1.95B | $1.77B | $1.83B | $1.83B | · | $1.59B | $1.56B | $1.46B | · | $1.60B | |
| Total Liabilities | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B | $30.03B | $32.38B | $33.37B | $33.91B | · | $38.90B | $39.56B | $38.14B | · | $34.45B | |
| Total Debt | $11.98B | $12.27B | · | $12.61B | $12.59B | $12.73B | · | $11.89B | $11.75B | $12.39B | · | $9.48B | $9.72B | $9.74B | · | $7.80B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $33M | |
| Retained Earnings | $30.74B | $30.15B | $29.07B | $29.98B | $29.89B | $29.45B | $28.32B | $29.12B | $28.75B | $28.17B | · | $28.19B | $27.47B | $26.62B | · | $25.61B | |
| Treasury Stock | $14.51B | $14.52B | $14.42B | $14.46B | $14.46B | $14.36B | $14.37B | $14.40B | $14.40B | $14.36B | · | $13.13B | $12.75B | $12.22B | · | $11.15B | |
| AOCI | $-751M | $-731M | $-633M | $-666M | $-783M | $-868M | $-1.07B | $-653M | $-1.12B | $-1.09B | · | $-1.50B | $-1.23B | $-1.11B | · | $-1.47B | |
| Stockholders' Equity | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B | $17.57B | $16.67B | $16.13B | · | $16.95B | $16.83B | $16.58B | · | $16.32B | |
| Liabilities + Equity | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Shares Outstanding | 198,720,000 | 198,720,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,691,000 | 198,690,000 | 198,690,000 | 198,690,000 | 198,667,000 | 198,667,000 | 198,667,000 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $159M | $163M | $164M | $173M | $178M | $183M | $208M | $210M | $212M | $209M | $201M | $201M | $191M | $186M | · | · | |
| Stock-based Comp | $65M | $51M | $48M | $83M | $61M | $49M | $54M | $53M | $55M | $45M | $33M | $53M | $51M | $38M | $43M | $80M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $-164M | $0 | · | · | $-67M | $-200M | |
| Amort. of Intangibles | $8M | $11M | $8M | $13M | $15M | $15M | $14M | $15M | $15M | $16M | $16M | $17M | $16M | $18M | $20M | $25M | |
| Operating Cash Flow | $1.97B | $1.25B | $-1.65B | $971M | $1.27B | $331M | $-528M | $1.86B | $1.21B | $423M | $-7.13B | $1.25B | $3.18B | $6.69B | $-5.13B | $8.45B | |
| CapEx | $132M | $121M | $202M | $135M | $114M | $95M | $154M | $130M | $114M | $177M | $283M | $234M | $264M | $223M | $275M | $288M | |
| Investing Cash Flow | $-273M | $-2.55B | $632M | $980M | $347M | $314M | $-63M | $-1.47B | $-1.00B | $-414M | $-882M | $-585M | $-733M | $-1.29B | $-1.01B | $1.68B | |
| Debt Issued | $0 | $990M | · | · | $0 | $1.48B | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $980M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1M | $107M | $42M | $0 | $100M | $9M | $49M | $2M | $49M | $717M | $571M | $379M | $529M | $94M | $1.06B | $4M | |
| Net Stock Activity | · | $-107M | · | · | · | $-9M | · | · | · | $-717M | · | · | · | $-94M | · | · | |
| Dividends Paid | $107M | $107M | $109M | $107M | $106M | $108M | $108M | $107M | $107M | $109M | $111M | $109M | $111M | $100M | $101M | $100M | |
| Financing Cash Flow | $249M | $2.05B | $-168M | $-603M | $-1.83B | $1.38B | $-2.30B | $-770M | $-620M | $1.21B | $-2.44B | $-1.73B | $36M | $3.28B | $-2.36B | $-1.79B | |
| Net Change in Cash | $1.94B | $751M | $-1.19B | $1.35B | $-210M | $2.03B | $-2.90B | $-385M | $-409M | $1.22B | $-10.45B | $-1.07B | $2.48B | $8.67B | $-8.50B | $8.34B | |
| Taxes Paid | $148M | $-7M | · | $122M | $41M | $-12M | · | $208M | $361M | $1M | · | $276M | $675M | $6M | $7M | $378M | |
| Free Cash Flow | · | $1.13B | · | · | · | $236M | · | · | · | $246M | · | · | · | $6.46B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $127M | · | · | · | $6.38B | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| Net Margin | 1.7% | 3.0% | · | 0.60% | 1.7% | 3.9% | · | 1.6% | 2.3% | 2.5% | · | 3.1% | 3.6% | 4.6% | · | 5.2% | |
| Pretax Margin | 2.3% | 4.0% | · | 0.41% | 2.3% | 5.3% | · | 2.2% | 3.0% | 3.3% | · | 4.1% | 4.7% | 6.0% | · | 5.7% | |
| EBITDA Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| ROA | 1.3% | 2.2% | · | 0.39% | 1.1% | 2.5% | · | 0.91% | 1.3% | 1.4% | · | 1.6% | 1.9% | 2.5% | · | 2.5% | |
| ROE | 3.7% | 6.5% | · | 1.1% | 3.1% | 7.3% | · | 2.8% | 4.0% | 4.5% | · | 5.0% | 5.9% | 7.8% | · | 7.3% | |
| ROIC | 3.3% | 4.3% | · | 2.1% | 2.7% | 5.0% | · | 1.9% | 3.0% | 3.2% | · | 3.5% | 4.1% | 5.1% | · | 4.5% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | 1.4 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.1 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.8 | · | 10.6 | 12.0 | 15.2 | · | 11.5 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 8.0 | 8.2 | · | 13.5 | 7.5 | 7.7 | · | 14.8 | 10.7 | 8.4 | · | 15.4 | 11.1 | 8.5 | · | 13.1 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $96.68 | $93.50 | · | $93.21 | $91.76 | $89.33 | · | $88.39 | $83.89 | $81.18 | · | $85.30 | $84.72 | $83.44 | · | $82.13 | |
| Revenue / Share | $337.37 | $328.61 | · | $270.40 | $268.23 | $265.73 | · | $243.43 | $244.81 | $244.18 | · | $213.12 | $213.79 | $212.98 | · | $179.02 | |
| Cash Flow / Share | · | $10.39 | · | · | · | $2.74 | · | · | · | $3.49 | · | · | · | $53.26 | · | · | |
| Cash / Share | $34.69 | $24.91 | · | $27.11 | $20.33 | $21.39 | · | $25.74 | $27.68 | $29.74 | · | $76.24 | $81.60 | $69.14 | · | $68.24 | |
| Dividend / Share | $0.89 | $0.89 | $0.89 | · | · | $0.89 | $0.89 | · | · | · | · | · | · | · | · | · | |
| Dividend Paid / Share | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | · | · | · | · | · | · | |
| EPS (TTM) | $10.59 | $9.37 | · | $10.70 | $13.06 | $14.17 | · | $11.47 | $14.20 | $16.24 | · | $24.16 | $26.84 | $24.66 | · | $22.05 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $145.68B | $137.20B | · | $126.36B | $123.11B | $120.26B | · | $115.01B | $112.04B | $109.24B | · | $102.35B | $98.73B | $95.64B | · | $91.48B | |
| Net Income TTM | $1.28B | $1.13B | · | $1.29B | $1.58B | $1.71B | · | $1.36B | $1.71B | $1.99B | · | $3.02B | $3.38B | $3.12B | · | $2.81B | |
| Market Cap | $78.94B | $34.46B | · | $51.70B | $48.58B | $52.58B | · | $62.94B | $74.25B | $68.89B | · | $96.67B | $88.84B | $96.44B | · | $96.39B | |
| Enterprise Value | $67.04B | $24.77B | · | $42.18B | $39.46B | $43.17B | · | $50.68B | $63.07B | $58.67B | · | $75.86B | $67.10B | $77.52B | · | $77.51B | |
| P/E | 37.5 | 18.5 | · | 24.3 | 18.7 | 18.7 | · | 27.6 | 26.3 | 21.3 | · | 20.1 | 16.7 | 19.7 | · | 22.0 | |
| P/S | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.7 | 0.6 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | |
| P/B | 4.1 | 1.9 | · | 2.8 | 2.7 | 3.0 | · | 3.6 | 4.5 | 4.3 | · | 5.7 | 5.3 | 5.8 | · | 5.9 | |
| P / Tangible Book | 10.5 | 5.0 | · | 6.7 | 6.7 | 7.9 | · | 10.0 | 13.6 | 14.1 | · | 17.1 | 16.1 | 17.5 | · | 17.8 | |
| P / Cash Flow | · | 27.5 | · | · | · | 158.9 | · | · | · | 162.9 | · | · | · | 14.4 | · | · | |
| EV / Revenue | 0.5 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | |
| Dividend Yield | 0.54% | 1.2% | · | 0.83% | 0.88% | 0.82% | · | 0.69% | 0.59% | 0.64% | · | 0.44% | 0.46% | 0.42% | · | 0.40% | |
| Earnings Yield | 2.7% | 5.4% | · | 4.1% | 5.3% | 5.4% | · | 3.6% | 3.8% | 4.7% | · | 5.0% | 6.0% | 5.1% | · | 4.5% | |
| Payout Ratio | · | 9.0% | · | · | · | 8.7% | · | · | · | 14.7% | · | · | · | 8.1% | · | · | |
| Annual Payout | $430M | $429M | · | $429M | $429M | $430M | · | $434M | $436M | $440M | · | $421M | $412M | $401M | · | $382M |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| 营业利润率 % | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% |
| 净收入 | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| 稀释后每股收益 (EPS) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 |
| 流动比率 | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 |
| 速动比率 | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $375M | $2.39B | $2.98B | $3.47B | $946M |
机构持有人 (13F) 1038 家申报者 · $52.7B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 248 (+126 与上一季度对比) | 85 (-76 与上一季度对比) | 325 (+68 与上一季度对比) | 288 (-56 与上一季度对比) | +3.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Dodge & Cox | $4345737744 | 10940380 | 8.25% | 股份 |
| BlackRock, Inc. | $4138159785 | 10417803 | 7.85% | 股份 |
| VANGUARD GROUP INC | $3652890202 | 14261860 | 6.93% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $3115642737 | 7843620 | 5.91% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2311405702 | 5818956 | 4.39% | 股份 |
| STATE STREET CORP | $2172441313 | 5457072 | 4.12% | 股份 |
| PZENA INVESTMENT MANAGEMENT LLC | $1749013682 | 4403136 | 3.32% | 股份 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $1664784292 | 3578245 | 3.16% | 股份 |
| EAGLE CAPITAL MANAGEMENT LLC | $1528010749 | 3846762 | 2.90% | 股份 |
| Sessa Capital IM, L.P. | $1480732883 | 3727740 | 2.81% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $1337386742 | 3369757 | 2.54% | 股份 |
| JPMORGAN CHASE & CO | $1257951102 | 3234637 | 2.39% | 股份 |
| FMR LLC | $1157405236 | 2913763 | 2.20% | 股份 |
| Capital International Investors | $950462637 | 2392826 | 1.80% | 股份 |
| GOLDMAN SACHS GROUP INC | $913562254 | 2299889 | 1.73% | 股份 |
| NAYA CAPITAL MANAGEMENT UK LTD | $728407339 | 1833763 | 1.38% | 股份 |
| NORGES BANK | $694505009 | 1748414 | 1.32% | 股份 |
| Invesco Ltd. | $587403999 | 1478788 | 1.11% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $544521489 | 1370831 | 1.03% | 股份 |
| MORGAN STANLEY | $535876914 | 1349066 | 1.02% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $445839059 | 1122669 | 0.85% | 股份 |
| Capital Research Global Investors | $443462035 | 1116990 | 0.84% | 股份 |
| NORTHERN TRUST CORP | $442978948 | 1115198 | 0.84% | 股份 |
| Slate Path Capital LP | $428969795 | 1079930 | 0.81% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $423436520 | 1066000 | 0.80% | 卖出期权 |
| Capital World Investors | $406119738 | 1022425 | 0.77% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $399841652 | 1006600 | 0.76% | 买入期权 |
| Newport Trust Company, LLC | $384768345 | 968653 | 0.73% | 股份 |
| CITADEL ADVISORS LLC | $363376856 | 914800 | 0.69% | 买入期权 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $348908912 | 878377 | 0.66% | 股份 |
| Legal & General Group Plc | $329760125 | 830170 | 0.63% | 股份 |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $314921577 | 792814 | 0.60% | 股份 |
| CITADEL ADVISORS LLC | $310904094 | 782700 | 0.59% | 卖出期权 |
| Allianz Asset Management GmbH | $307098329 | 773119 | 0.58% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $304014312 | 765355 | 0.58% | 股份 |
| BANK OF AMERICA CORP /DE/ | $279490113 | 703615 | 0.53% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $267791027 | 674163 | 0.51% | 股份 |
| Maple Rock Capital Partners Inc. | $249553862 | 628251 | 0.47% | 股份 |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $245555446 | 618185 | 0.47% | 股份 |
| Bank of New York Mellon Corp | $238144113 | 599527 | 0.45% | 股份 |
| GOLDMAN SACHS GROUP INC | $232333978 | 584900 | 0.44% | 买入期权 |
| MARSHALL WACE, LLP | $216873381 | 545978 | 0.41% | 股份 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $189649820 | 1093776 | 0.36% | 股份 |
| CITADEL ADVISORS LLC | $178360519 | 449022 | 0.34% | 股份 |
| High Ground Investment Management LLP | $177941848 | 447968 | 0.34% | 股份 |
| 1832 Asset Management L.P. | $176401430 | 444090 | 0.33% | 股份 |
| BCV Asset Management Inc. | $173695656 | 445719 | 0.33% | 股份 |
| Nuveen, LLC | $167646743 | 422051 | 0.32% | 股份 |
| Holocene Advisors, LP | $165040541 | 415489 | 0.31% | 股份 |
| DEUTSCHE BANK AG\ | $163345207 | 411221 | 0.31% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| David A. Jones ×2 申报 | 2003年11月12日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 79 位内幕人士 · 48 位高管 · 29 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| James A. Rechtin | President & CEO | 2026年5月1日 A | 63938 | 0 | 0 | $0 |
| Bruce D Broussard | Chief Executive Officer | 2024年2月21日 A | 110130 | 0 | 0 | $0 |
| Celeste Mellet | Chief Financial Officer | 2026年5月1日 A | 39637 | 0 | 0 | $0 |
| Susan M Diamond | Chief Financial Officer | 2024年12月31日 J | 20165 | 0 | 0 | $0 |
| Brian A Kane | Chief Financial Officer | 2021年2月22日 A | 24342 | 0 | 0 | $0 |
| Steven E Mcculley | Interim CFO & Treasurer | 2014年5月9日 G | 14916 | 0 | 0 | $0 |
| Aaron Martin | President, Medicare Advantage | 2026年5月1日 A | 25237 | 0 | 0 | $0 |
| David Dintenfass | President, Enterprise Growth | 2026年5月1日 A | 25407 | 0 | 0 | $0 |
| Sanjay K Shetty | President, CenterWell | 2026年5月1日 A | 22088 | 1 | 0 | $150012 |
| George Renaudin II | President, Insurance | 2026年3月31日 J | 16075 | 0 | 0 | $0 |
| M.D. Andrew C. Agwunobi, | Seg. President, Home Solutions | 2023年2月24日 A | 182 | 0 | 0 | $0 |
| Timothy Alan Wheatley | Segment President, Retail | 2022年12月15日 M | 3983 | 0 | 0 | $0 |
| Joseph William Jasser | Seg. President, Care Delivery | 2017年12月15日 M | 222 | 0 | 0 | $0 |
| Thomas J Liston | President - Retail Segment | 2014年2月18日 A | 105443 | 0 | 0 | $0 |
| James E Murray | EVP & COO | 2017年3月31日 J | 34668 | 0 | 0 | $0 |
| Shantanu Nundy | Chief Medical Officer | 2026年9月1日 A | 2549 | 0 | 0 | $0 |
| Japan Mehta | Chief Information Officer | 2026年5月1日 A | 17176 | 0 | 0 | $0 |
| Michelle A. O'Hara | Chief Human Resources Officer | 2026年5月1日 A | 20026 | 0 | 0 | $0 |
| Joseph C Ventura | Chief Legal Officer | 2026年5月1日 A | 27405 | 0 | 0 | $0 |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | 2026年2月24日 F | 7484 | 0 | 0 | $0 |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | 2025年2月24日 A | 16717 | 0 | 0 | $0 |
| Timothy S. Huval | Chief Administrative Officer | 2024年12月31日 G | 7111 | 0 | 0 | $0 |
| Samir Deshpande | Chief Information Officer | 2024年12月15日 M | 14015 | 0 | 0 | $0 |
| William Kevin Fleming | Chief Corporate Aff. Officer | 2024年2月21日 A | 11723 | 0 | 0 | $0 |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | 2023年2月24日 F | 3687 | 0 | 0 | $0 |
| William H Shrank | Chief Medical Officer | 2022年5月1日 M | 4294 | 0 | 0 | $0 |
| Cynthia H Zipperle | SVP, Chief Acct Officer & Cont | 2022年3月22日 J | 5723 | 0 | 0 | $0 |
| Heather Cox | Chief Dig Health & Analyt Off. | 2022年2月25日 F | 6014 | 0 | 0 | $0 |
| Christopher H. Hunter | Seg Pres. Gr. & Military Bus. | 2021年3月16日 G | 8168 | 0 | 0 | $0 |
| Elizabeth D Bierbower | Strategic Advisor | 2019年12月18日 M | 18092 | 0 | 0 | $0 |
| Brian P. Leclaire | Strategic Advisor | 2019年12月15日 M | 6339 | 0 | 0 | $0 |
| Jody L Bilney | Chief Consumer Officer | 2019年2月25日 A | 9774 | 0 | 0 | $0 |
| Roy A Beveridge, | Chief Medical Officer | 2019年2月19日 M | 10791 | 0 | 0 | $0 |
| Todoroff M Christopher | Chief Legal Officer | 2018年12月15日 M | 11136 | 0 | 0 | $0 |
| Heidi S Margulis | Chief Corp. Affairs Officer | 2018年12月15日 M | 6476 | 0 | 0 | $0 |
| Christopher E Kay | SVP & Chief Innovation Officer | 2017年3月17日 M | 4361 | 0 | 0 | $0 |
| Tim S Mcclain | Group Pres, Govt & Other Busin | 2014年2月18日 A | 1101 | 0 | 0 | $0 |
| Bruce D Perkins | Sgmt Pres, Healthcare Services | 2014年2月18日 A | 15946 | 0 | 0 | $0 |
| Paul B. K. Kusserow | Sr VP & Ch Strat Dev Officer | 2013年6月24日 M | 19347 | 0 | 0 | $0 |
| HATHCOCK BONNIE C | Sr VP & Chief Human Res. Off | 2012年12月24日 G | 2287 | 0 | 0 | $0 |
| Venkata R Madabhushi | SVP & Chief Innov & Mrkting Of | 2012年4月28日 F | 11946 | 0 | 0 | $0 |
| GOODMAN BRUCE J | Sr. VP | 2012年2月23日 A | 23280 | 0 | 0 | $0 |
| Jonathan T Lord MD | Sr VP & Chief Innovation Off. | 2009年2月4日 I | 0 | 0 | 0 | $0 |
| Arthur P Hipwell | Senior Vice President | 2008年3月27日 J | 302 | 0 | 0 | $0 |
| Kathleen Pellegrino | VP and Acting General Counsel | 2008年2月25日 F | 13836 | 0 | 0 | $0 |
| Steven O Moya | Sr. VP-Chief Marketing Officer | 2007年12月31日 I | 0 | 0 | 0 | $0 |
| John M Bertko | Vice President & Chief Actuary | 2007年2月23日 M | 57548 | 0 | 0 | $0 |
| Eugene R Shields | Senior Vice President-Gov Prgm | 2005年1月6日 M | 0 | 0 | 0 | $0 |
| Kurt J Hilzinger | 董事 | 2026年9月30日 A | 19448 | 0 | 0 | $0 |
| Paul John Smith | 董事 | 2026年8月1日 A | 544 | 0 | 0 | $0 |
| Robert Stuart Field | 董事 | 2026年5月1日 A | 852 | 0 | 0 | $0 |
| Jorge S. Mesquita | 董事 | 2026年1月2日 A | 4127 | 0 | 0 | $0 |
| Frank A Damelio | 董事 | 2026年1月2日 A | 20634 | 0 | 0 | $0 |
| Raquel C. Bono | 董事 | 2025年12月31日 A | 397 | 0 | 0 | $0 |
| Wayne A.I. Frederick | 董事 | 2025年12月31日 A | 440 | 0 | 0 | $0 |
| Marcy S Klevorn | 董事 | 2025年12月31日 A | 436 | 0 | 0 | $0 |
| John W Garratt | 董事 | 2025年12月31日 A | 1685 | 0 | 0 | $0 |
| David T Feinberg | 董事 | 2025年12月31日 A | 1207 | 0 | 0 | $0 |
| Karen Katz | 董事 | 2025年12月31日 A | 590 | 0 | 0 | $0 |
| Brad D Smith | 董事 | 2024年12月31日 A | 1169 | 0 | 0 | $0 |
| William J. Mcdonald | 董事 | 2024年1月2日 A | 2276 | 0 | 0 | $0 |
| JONES DAVID A JR/KY | 董事 | 2023年2月28日 G | 32440 | 0 | 0 | $0 |
| OBRIEN JAMES J /KY | 董事 | 2023年1月3日 A | 1794 | 0 | 0 | $0 |
| Marissa T Peterson | 董事 | 2022年1月3日 A | 2044 | 0 | 0 | $0 |
| Frank Bisignano | 董事 | 2021年1月4日 A | 2727 | 0 | 0 | $0 |
| Webster Roy Dunbar | 董事 | 2019年12月31日 A | 2880 | 0 | 0 | $0 |
| Karen B Desalvo | 董事 | 2019年1月2日 A | 634 | 0 | 0 | $0 |
| David Nash | 董事 | 2019年1月2日 A | 112 | 0 | 0 | $0 |
| William Mitchell | 董事 | 2018年12月31日 A | 688 | 0 | 0 | $0 |
| Michael B Mccallister | 董事 | 2013年12月31日 M | 113885 | 0 | 0 | $0 |
| Ann W Reynolds | 董事 | 2011年5月15日 M | 39727 | 0 | 0 | $0 |
| James O Robbins | 董事 | 2007年1月3日 A | · | 0 | 0 | $0 |
| HALL JOHN R /KY | 董事 | 2006年1月3日 A | 22423 | 0 | 0 | $0 |
| JONES DAVID A SR/KY | 董事 | 2005年4月5日 G | 4777524 | 0 | 0 | $0 |
| Michael E Gellert | 董事 | 2005年1月3日 A | 60237 | 0 | 0 | $0 |
| Irwin Lerner | 董事 | 2004年1月2日 A | 30637 | 0 | 0 | $0 |
| Frederick John Crawford | · | 2026年8月1日 A | 544 | 0 | 0 | $0 |
| Gordon Smith | · | 2025年12月31日 A | 765 | 0 | 0 | $0 |
| James H Bloem | · | 2013年11月7日 M | 30326 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
ETF持仓 由 143 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IHF · iShares Trust | 4.63% | 151582 SH | 2026年9月11日 | 每日 |
| FMTM · EA Series Trust | 3.07% | 21303 NS | 2026年7月31日 | N-PORT |
| TGLB · T. Rowe Price Exchange-Traded Fun... | 2.57% | 1854 NS | 2026年7月31日 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2.35% | 103450 SH | 2026年10月2日 | 每日 |
| SRHQ · Elevation Series Trust | 2.31% | 13473 NS | 2026年7月31日 | N-PORT |
| EPMV · Harbor ETF Trust | 1.75% | 225 NS | 2026年7月31日 | N-PORT |
| CVAR · ETF Opportunities Trust | 1.71% | 2014 NS | 2026年7月31日 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.57% | 35951 SH | 2026年10月2日 | 每日 |
| NUMV · Nushares ETF Trust | 1.39% | 16939 NS | 2026年7月31日 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund ... | 1.16% | 290 NS | 2026年7月31日 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0.88% | 32276 NS | 2026年7月31日 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0.82% | 771237 SH | 2026年8月19日 | 每日 |
| IYH · iShares Trust | 0.78% | 70303 SH | 2026年9月11日 | 每日 |
| JOET · Virtus ETF Trust II | 0.74% | 4940 NS | 2026年7月31日 | N-PORT |
| PALC · Pacer Funds Trust | 0.74% | 4248 NS | 2026年7月31日 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trus... | 0.71% | 181374 SH | 2026年10月2日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.70% | 360880 SH | 2026年8月19日 | 每日 |
| PDP · Invesco Exchange-Traded Fund Trust | 0.70% | 27208 SH | 2026年10月2日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.63% | 57108 NS | 2026年7月31日 | N-PORT |
| IXJ · iShares Trust | 0.61% | 63215 SH | 2026年9月11日 | 每日 |
| CURE · Direxion Shares ETF Trust | 0.50% | 2362 NS | 2026年7月31日 | N-PORT |
| IWS · iShares Trust | 0.47% | 179478 SH | 2026年9月11日 | 每日 |
| VO · VANGUARD INDEX FUNDS | 0.46% | 2601869 SH | 2026年8月19日 | 每日 |
| IMCV · iShares Trust | 0.40% | 11586 SH | 2026年9月11日 | 每日 |
| MTUM · iShares Trust | 0.37% | 227558 SH | 2026年9月11日 | 每日 |
| IWR · iShares Trust | 0.35% | 492212 SH | 2026年9月11日 | 每日 |
| PRF · Invesco Exchange-Traded Fund Trust | 0.34% | 88063 SH | 2026年10月2日 | 每日 |
| IMCB · iShares Trust | 0.34% | 14123 SH | 2026年9月11日 | 每日 |
| VRP · Invesco Exchange-Traded Fund Trus... | 0.33% | 10420000 | 2026年10月2日 | 每日 |
| FFLC · FIDELITY COVINGTON TRUST | 0.32% | 10722 NS | 2026年7月31日 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Inde... | 0.32% | 8116 SH | 2026年10月2日 | 每日 |
| IMCG · iShares Trust | 0.27% | 27157 SH | 2026年9月11日 | 每日 |
| XOEF · iShares Trust | 0.27% | 151 SH | 2026年9月11日 | 每日 |
| VLUE · iShares Trust | 0.26% | 62879 SH | 2026年9月11日 | 每日 |
| PFIG · Invesco Exchange-Traded Fund Trus... | 0.25% | 320000 | 2026年10月2日 | 每日 |
| SIZE · iShares Trust | 0.24% | 2599 SH | 2026年9月11日 | 每日 |
| BSCS · Invesco Exchange-Traded Self-Inde... | 0.23% | 8027000 | 2026年10月2日 | 每日 |
| ROUS · Lattice Strategies Trust | 0.23% | 4462 NS | 2026年7月31日 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Inde... | 0.22% | 9983000 | 2026年10月2日 | 每日 |
| EUSA · iShares, Inc. | 0.22% | 10324 SH | 2026年9月11日 | 每日 |
| HELO · J.P. Morgan Exchange-Traded Fund ... | 0.21% | 26395 NS | 2026年7月31日 | N-PORT |
| CATH · Global X Funds | 0.21% | 7419 NS | 2026年7月31日 | N-PORT |
| VYM · VANGUARD WHITEHALL FUNDS | 0.20% | 479438 SH | 2026年8月19日 | 每日 |
| RSP · Invesco Exchange-Traded Fund Trust | 0.19% | 487833 SH | 2026年10月2日 | 每日 |
| EVUS · iShares Trust | 0.19% | 1842 SH | 2026年9月11日 | 每日 |
| USXF · iShares Trust | 0.19% | 7125 SH | 2026年9月11日 | 每日 |
| ESMV · iShares Trust | 0.19% | 37 SH | 2026年9月11日 | 每日 |
| SUSA · iShares Trust | 0.19% | 19078 SH | 2026年9月11日 | 每日 |
| ACVF · ETF Opportunities Trust | 0.19% | 790 NS | 2026年7月31日 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0.18% | 1140642 SH | 2026年8月19日 | 每日 |
| DFLV · Dimensional ETF Trust | 0.18% | 32943 NS | 2026年7月31日 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund ... | 0.17% | 3921 NS | 2026年7月31日 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.17% | 3648 SH | 2026年8月19日 | 每日 |
| DFSU · Dimensional ETF Trust | 0.17% | 10472 NS | 2026年7月31日 | N-PORT |
| IVE · iShares Trust | 0.16% | 200080 SH | 2026年9月11日 | 每日 |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.16% | 27648 SH | 2026年8月19日 | 每日 |
| IUSV · iShares Trust | 0.15% | 104740 SH | 2026年9月11日 | 每日 |
| VEGN · ETF Series Solutions | 0.15% | 709 NS | 2026年7月31日 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.14% | 60086 NS | 2026年7月31日 | N-PORT |
| SUSL · iShares Trust | 0.14% | 4238 SH | 2026年9月11日 | 每日 |
| FYEE · Fidelity Greenwood Street Trust | 0.14% | 839 NS | 2026年7月31日 | N-PORT |
| DSI · iShares Trust | 0.14% | 18418 SH | 2026年9月11日 | 每日 |
| IQSU · New York Life Investments ETF Trust | 0.14% | 1230 NS | 2026年7月31日 | N-PORT |
| CHRI · Global X Funds | 0.13% | 29 NS | 2026年7月31日 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.13% | 72504 SH | 2026年8月19日 | 每日 |
| IWD · iShares Trust | 0.13% | 267199 SH | 2026年9月11日 | 每日 |
| BSCT · Invesco Exchange-Traded Self-Inde... | 0.12% | 3809000 | 2026年10月2日 | 每日 |
| NULV · Nushares ETF Trust | 0.11% | 6797 NS | 2026年7月31日 | N-PORT |
| ESGU · iShares Trust | 0.11% | 47962 SH | 2026年9月11日 | 每日 |
| DGRO · iShares Trust | 0.10% | 111232 SH | 2026年9月11日 | 每日 |
| EGLE · Global X Funds | 0.10% | 6 NS | 2026年7月31日 | N-PORT |
| GLBL · Pacer Funds Trust | 0.10% | 3 NS | 2026年7月31日 | N-PORT |
| LQAI · Exchange Listed Funds Trust | 0.10% | 6 NS | 2026年7月31日 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trus... | 0.09% | 1886 SH | 2026年10月2日 | 每日 |
| TOPC · iShares Trust | 0.09% | 72 SH | 2026年9月11日 | 每日 |
| ILCV · iShares Trust | 0.08% | 2783 SH | 2026年9月11日 | 每日 |
| XVV · iShares Trust | 0.08% | 1375 SH | 2026年9月11日 | 每日 |
| VV · VANGUARD INDEX FUNDS | 0.08% | 140219 SH | 2026年8月19日 | 每日 |
| ESGV · VANGUARD WORLD FUND | 0.08% | 27152 SH | 2026年8月19日 | 每日 |
| QVML · Invesco Exchange-Traded Fund Trus... | 0.08% | 3447 SH | 2026年10月2日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.08% | 100648 NS | 2026年7月31日 | N-PORT |
| XTR · Global X Funds | 0.08% | 10 NS | 2026年7月31日 | N-PORT |
| IVV · iShares Trust | 0.07% | 1513176 SH | 2026年9月11日 | 每日 |
| ILCB · iShares Trust | 0.07% | 2328 SH | 2026年9月11日 | 每日 |
| XCLR · Global X Funds | 0.07% | 7 NS | 2026年7月31日 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.07% | 3119147 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.07% | 3812375 SH | 2026年8月19日 | 每日 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.07% | 19809 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.07% | 10113 SH | 2026年8月19日 | 每日 |
| PBP · Invesco Exchange-Traded Fund Trust | 0.07% | 715 SH | 2026年10月2日 | 每日 |
| PBUS · Invesco Exchange-Traded Fund Trus... | 0.07% | 20848 SH | 2026年10月2日 | 每日 |
| IYY · iShares Trust | 0.07% | 5172 SH | 2026年9月11日 | 每日 |
| IWB · iShares Trust | 0.07% | 82919 SH | 2026年9月11日 | 每日 |
| XYLD · Global X Funds | 0.07% | 6091 NS | 2026年7月31日 | N-PORT |
| PTLC · Pacer Funds Trust | 0.07% | 6112 NS | 2026年7月31日 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund ... | 0.07% | 16615 NS | 2026年7月31日 | N-PORT |
| USCL · iShares Trust | 0.07% | 4768 SH | 2026年9月11日 | 每日 |
| VOTE · TCW ETF Trust | 0.07% | 2035 NS | 2026年7月31日 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0.07% | 10127 NS | 2026年7月31日 | N-PORT |
| XRMI · Global X Funds | 0.07% | 92 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.07% | 33101 SH | 2026年9月11日 | 每日 |
| ITOT · iShares Trust | 0.07% | 156223 SH | 2026年9月11日 | 每日 |
| LRGF · iShares Trust | 0.06% | 5842 SH | 2026年9月11日 | 每日 |
| DXUV · Dimensional ETF Trust | 0.06% | 959 NS | 2026年7月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.06% | 36333 NS | 2026年7月31日 | N-PORT |
| XYLG · Global X Funds | 0.06% | 111 NS | 2026年7月31日 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0.06% | 453 NS | 2026年7月31日 | N-PORT |
| ILCG · iShares Trust | 0.06% | 4804 SH | 2026年9月11日 | 每日 |
| QDPL · Pacer Funds Trust | 0.06% | 2883 NS | 2026年7月31日 | N-PORT |
| TOV · EA Series Trust | 0.06% | 454 NS | 2026年7月31日 | N-PORT |
| TILT · FlexShares Trust | 0.06% | 3564 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.06% | 20053 NS | 2026年7月31日 | N-PORT |
| PHDG · Invesco Actively Managed Exchange... | 0.06% | 95 SH | 2026年10月2日 | 每日 |
| VOXP · Advisors Series Trust | 0.06% | 9 NS | 2026年7月31日 | N-PORT |
| TOK · iShares Trust | 0.06% | 333 SH | 2026年9月11日 | 每日 |
| HCMT · Direxion Shares ETF Trust | 0.05% | 835 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.05% | 4948 NS | 2026年7月31日 | N-PORT |
| URTH · iShares, Inc. | 0.05% | 10772 SH | 2026年9月11日 | 每日 |
| SPXL · Direxion Shares ETF Trust | 0.05% | 9382 NS | 2026年7月31日 | N-PORT |
| ACWI · iShares Trust | 0.05% | 38539 SH | 2026年9月11日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.04% | 196805 SH | 2026年8月19日 | 每日 |
| OMFL · Invesco Exchange-Traded Self-Inde... | 0.04% | 4718 SH | 2026年10月2日 | 每日 |
| NEAR · iShares U.S. ETF Trust | 0.03% | 1504000 SH | 2026年9月11日 | 每日 |
| GLOF · iShares Trust | 0.02% | 106 SH | 2026年9月11日 | 每日 |
| DYNF · BlackRock ETF Trust | 0.01% | 14919 SH | 2026年9月11日 | 每日 |
| CRBN · iShares Trust | 0.01% | 383 SH | 2026年9月11日 | 每日 |
| VXUS · VANGUARD STAR FUNDS | 0.00% | 4397881 SH | 2026年8月19日 | 每日 |
| VPL · VANGUARD INTERNATIONAL EQUITY IND... | 0.00% | 401850 SH | 2026年8月19日 | 每日 |
| VSS · VANGUARD INTERNATIONAL EQUITY IND... | 0.00% | 932492 SH | 2026年8月19日 | 每日 |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.00% | 2391019 SH | 2026年8月19日 | 每日 |
| VSGX · VANGUARD WORLD FUND | 0.00% | 54062 SH | 2026年8月19日 | 每日 |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 2026年7月15日 | 每日 |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 2026年7月15日 | 每日 |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 2026年7月15日 | 每日 |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 2026年7月15日 | 每日 |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 2026年7月15日 | 每日 |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 2026年7月15日 | 每日 |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 2026年7月15日 | 每日 |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 2026年7月15日 | 每日 |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 2026年7月15日 | 每日 |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 2026年7月30日 | 每日 |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 2026年7月30日 | 每日 |
| VCEB · VANGUARD WORLD FUND | · | · | 2026年7月30日 | 每日 |
HUM 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
12个月价格目标
23 位分析师 · 2026-09-30平均目标 $423.74 +9.1%
同行比较(GICS 子行业) 关键指标与行业同行对比
财年依据,价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存,并会跟随您浏览所有股票。